Crossmark

3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors

Published Online: 2024-10-28

Authors

Hays, William Blake

Billups, Kelsey

Nicholson, Jessica

Bailey, Abby M.

Gregory, Haili

Weeda, Erin R.

Weant, Kyle A. https://orcid.org/0000-0003-0835-7955
License Information

Text and Data Mining valid from 2024-10-28

Version of Record valid from 2024-10-28
More Information

Article History

Accepted: 11 October 2024

First Online: 28 October 2024

Declarations

:

: These authors have nothing to disclose.

Document is current